These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 3119021
1. The natural course of gold nephropathy: long term study of 21 patients. Hall CL, Fothergill NJ, Blackwell MM, Harrison PR, MacKenzie JC, MacIver AG. Br Med J (Clin Res Ed); 1987 Sep 26; 295(6601):745-8. PubMed ID: 3119021 [Abstract] [Full Text] [Related]
7. Gold nephropathy in juvenile rheumatoid arthritis. Husserl FE, Shuler SE. Am J Dis Child; 1979 Jan 26; 133(1):50-2. PubMed ID: 104619 [Abstract] [Full Text] [Related]
8. Gold-induced immune complex nephritis in seronegative rheumatoid arthritis. Skrifvars BV, Törnroth TS, Tallqvist GN. Ann Rheum Dis; 1977 Dec 26; 36(6):549-56. PubMed ID: 145832 [Abstract] [Full Text] [Related]
9. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ. N Engl J Med; 1980 Aug 07; 303(6):300-2. PubMed ID: 6770269 [Abstract] [Full Text] [Related]
10. Gold nephropathy in rabbits using an indigenous preparation. A morphological study. Nagi AH, Khan AH. Int Urol Nephrol; 1984 Aug 07; 16(1):49-59. PubMed ID: 6427132 [Abstract] [Full Text] [Related]
11. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis. Bensen WG, Moore N, Tugwell P, D'Souza M, Singal DP. J Rheumatol; 1984 Jun 07; 11(3):358-61. PubMed ID: 6234391 [Abstract] [Full Text] [Related]
13. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis. Obayashi M, Uzu T, Harada T, Yamato M, Takahara K, Yamauchi A. Clin Exp Nephrol; 2003 Dec 07; 7(4):275-8. PubMed ID: 14712356 [Abstract] [Full Text] [Related]
14. [Studies of protein clearance in patients treated with and without gold preparations in rheumatoid arthritis]. Gräfenstein K. Z Gesamte Inn Med; 1987 Jan 15; 42(2):56-8. PubMed ID: 3107230 [Abstract] [Full Text] [Related]
15. Gold therapy in rheumatoid arthritis. Schorn D, Anderson IF. S Afr Med J; 1975 Aug 30; 49(37):1505-6. PubMed ID: 125934 [Abstract] [Full Text] [Related]
16. [Conspicuous accumulation of membranous glomerulonephritis following gold therapy in chronic polyarthritis--a side effect of a new preparation?]. Burger HR, Briner J, Spycher MA. Schweiz Med Wochenschr; 1979 Mar 24; 109(12):423-31. PubMed ID: 106466 [Abstract] [Full Text] [Related]
17. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Bacon PA, Tribe CR, Mackenzie JC, Verrier-Jones J, Cumming RH, Amer B. Q J Med; 1976 Oct 24; 45(180):661-84. PubMed ID: 1005658 [Abstract] [Full Text] [Related]
18. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine. Domljan Z, Borso G, Marinković M, Winter Fudurić I, Pucar I, Cikes N. Acta Med Iugosl; 1987 Oct 24; 41(5):363-72. PubMed ID: 3128058 [No Abstract] [Full Text] [Related]
19. Gold treatment for rheumatoid arthritis: reassurance on proteinuria. Collins AJ. Br Med J (Clin Res Ed); 1987 Sep 26; 295(6601):739-40. PubMed ID: 3119018 [No Abstract] [Full Text] [Related]
20. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy. Billingsley LM, Stevens MB. Johns Hopkins Med J; 1981 Feb 26; 148(2):64-7. PubMed ID: 7206401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]